NDC properties for "Revlimid 25 MG Oral Capsule" (RxCUI 643722)
About this data
The tables show NDC propoerties for Revlimid 25 MG Oral Capsule with the RxCUI 643722
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Revlimid 25 MG Oral Capsule (RxCUI 643722)
| MMSL_CODE | BD16978 |
|---|---|
| NDA | NDA021880 |
| RxCUI | 643722 |
| SPL_SET_ID | 5fa97bf5-28a2-48f1-8955-f56012d296be |
| Prescribable Synonym | Revlimid 25 MG Oral Capsule |
| RXNAV_STR | Revlimid 25 MG Oral Capsule |
| RxNorm Name | lenalidomide 25 MG Oral Capsule [Revlimid] |
| RxNorm Synonym | Revlimid 25 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 643722) |
NDC Properties
NDC Item 59572042500
| NDC 9 | 59572-425 |
|---|---|
| NDC 10 | 59572-425-00 |
| NDC Item | 59572042500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-425-00) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;25;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-425 |
NDC Item 59572042521
| NDC 9 | 59572-425 |
|---|---|
| NDC 10 | 59572-425-21 |
| NDC Item | 59572042521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59572-425-21) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;25;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-425 |
NDC Item 59572042500
| NDC 9 | 59572-425 |
|---|---|
| NDC 10 | 59572-425-00 |
| NDC Item | 59572042500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-425-00) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;25;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-425 |
NDC Item 59572042521
| NDC 9 | 59572-425 |
|---|---|
| NDC 10 | 59572-425-21 |
| NDC Item | 59572042521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59572-425-21) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;25;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-425 |